| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 129,635 | 149,046 | 175,417 | 205,911 | | Cost of Revenue | 94,281 | 108,251 | 130,358 | 151,579 | | | Gross Profit | 35,354 | 40,795 | 45,059 | 54,332 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 28,858 | 32,803 | 34,664 | 39,052 | | Non Recurring | (227) |
-
|
-
| 244,094 | | Others | 2,963 | 3,495 | 3,233 | 3,685 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 3,760 | 4,497 | 7,162 | (232,500) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 175 | (86) | 73 | 13 | | Earnings Before Interest And Taxes | (943) | 4,411 | 7,235 | (232,487) | | Interest Expense | (3,214) | 1,513 | 1,701 | 2,265 | | Income Before Tax | 2,271 | 2,898 | 5,534 | (234,751) | | Income Tax Expense | 1,303 | 606 | 2,498 | (73,415) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 968 | 2,292 | 3,036 | (161,337) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 968 | 2,292 | 3,036 | (161,337) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $968 | $2,292 | $3,036 | ($161,337) |
|
1.48% Nasdaq 
Income Statement
